Array BioPharma Slaps $192M Lawsuit on AstraZeneca Over Cancer Drug Royalties Post author:Sam Post published:February 1, 2018 Post category:BioPharma AstraZeneca did not immediately respond to a request for comment. Source: BioSpace You Might Also Like Novartis AG Remains Hush-Hush About CAR-T Trial But the FDA is Impressed and Thinks It's a Breakthrough April 17, 2017 Merrimack Pharmaceuticals Expands Phase II Lung Cancer Study March 11, 2018 Former Pfizer Neuroscientist to Helm New York Biotech March 30, 2017
Novartis AG Remains Hush-Hush About CAR-T Trial But the FDA is Impressed and Thinks It's a Breakthrough April 17, 2017
